VRPX - JinkoSolar Holding Chemomab Therapeutics among premarket losers' pack
Provention Bio (PRVB) -38% after gives update on teplizumab BLA, FDA feedback.Virpax Pharmaceuticals (VRPX) -18%.Chemomab Therapeutics (CMMB) -17%.Iterum Therapeutics (ITRM) -15% after receiving notice from FDA on its NDA drug application for sulopenem etzadroxil/probenecid for the treatment of uncomplicated urinary tract infections in patients with a quinolone non-susceptible pathoge.Medalist Diversified REIT (MDRR) -14% after pricing public offering.Vericity (VERY) -9%.JinkoSolar Holding (JKS) -7% on Q4 earnings release.Immutep (IMMP) -7%.Oncternal Therapeutics (ONCT) -6%.Global Ship Lease (GSL) -6% on secondary offeringStealth BioTherapeutics (MITO) -6%.AeroCentury (ACY) -5%.
For further details see:
JinkoSolar Holding, Chemomab Therapeutics among premarket losers' pack